Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00755716 · ClinicalTrials.gov registry record · Phase 3
Topiramate Alone and in Combination With the Nicotine Patch for Smoking Cessation: A Pilot Study
A Phase 3 study, sponsored by UConn Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 57
- Enrollment target
NCT00755716 is a Phase 3 study that has completed, run by UConn Health. The registered enrollment target is 57 participants.
The verdict
NCT00755716, a Phase 3 study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 57 participants
- Enrollment target
Study Summary
Specific aims: 1. To obtain pilot data on 4-week continuous quit rates associated with 10 weeks of treatment with topiramate or placebo or topiramate plus nicotine patch for smoking cessation. 2. To obtain pilot data on the effects of 10 weeks of topiramate versus placebo versus combination of topiramate plus nicotine patch on nicotine withdrawal symptoms, smoking satisfaction, and adverse effects during smoking cessation. 3. To obtain pilot data on weight gain over 10 weeks with topiramate versus placebo versus combination of topiramate plus nicotine patch for smoking cessation.
Interventions
- DRUG Nicotine patch
- DRUG Topiramate
- DRUG Placebo (sugar pill)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2006-04 |
| Est. Completion | 2013-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00755716
The ClinicalTrials.gov registry entry for NCT00755716 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nicotine patch is the first listed.
NCT00755716 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00755716 about?
NCT00755716 is a clinical study titled "Topiramate Alone and in Combination With the Nicotine Patch for Smoking Cessation: A Pilot Study". Specific aims: 1. To obtain pilot data on 4-week continuous quit rates associated with 10 weeks of treatment with topiramate or placebo or topiramate plus nicotine patch for smoking cessation. 2. To obtain pilot data on the effects of 10 weeks of topiramate versus placebo versus combination of topi...
What is the current status of trial NCT00755716?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 57 participants. The study started on 2006-04. Estimated completion is 2013-08.
What interventions are being tested in trial NCT00755716?
The interventions under investigation include: Nicotine patch (DRUG), Topiramate (DRUG), Placebo (sugar pill) (DRUG).
Who is sponsoring clinical trial NCT00755716?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.